Full Text View
Tabular View
No Study Results Posted
Related Studies
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by Eyetech Pharmaceuticals.
Recruitment status was  Recruiting
Study NCT00354445   Information provided by Eyetech Pharmaceuticals

First Received on July 18, 2006.   Last Updated on January 12, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
pegaptanib sodium (Macugen)
Sponsors listed in this trial
Eyetech Pharmaceuticals
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services